Barclays Reiterates an 'Underweight' on Zumiez (ZUMZ); Lowers EPS Estimates & PT

Barclays reiterates an 'Underweight' on Zumiez, Inc. (NASDAQ: ZUMZ) price target lowered by $1 to $19.

Barclays analyst says, "ZUMZ reported 2Q FY11 EPS of $0.08, $0.03 better than us and consensus of $0.05. The $0.03 beat was operating due to higher gross margin and lower SG&A expense. Management provided guidance for 3Q/11 of $0.37 to $0.39 on a positive low single digit comp versus consensus of $0.44 and us at $0.41. We are lowering our 3Q 2011 EPS estimate to $0.37 from $0.41, 4Q to $0.53 from $0.55, FY 2011 to $1.05 from $1.08, and FY 2012 to $1.22 from $1.25."

For more ratings news on Zumiez, Inc. click here and for the rating history of Zumiez, Inc. click here.

Shares of Zumiez, Inc. closed at $18.49 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Barclays Upgrades Schott Pharma AG (1SXP:GR) to Overweight
• UBS Downgrades Planisware SA (PLNW:FP) to Neutral
• Bernstein SocGen Group Upgrades Whitbread PLC. (WTB:LN) (WTBCF) to Market Perform